HO

Hematological Oncology

Hematological Oncology is a peer-reviewed journal at the interface of hematology and oncology research. It publishes experimental and clinical articles on blood cancers and neoplastic diseases of the hemopoietic and lymphoid systems, including translational studies, clinical practice and management of hematological neoplasia, diagnostic investigations, imaging and laboratory assays, and therapeutic issues.

Looking to publish in Hematological Oncology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Hematology, Oncology
Impact Factor 3.9
Quartile Q1
Open Access Type Hybrid
ISSN 0278-0232
eISSN 1099-1069
Invitation Only No
Cost Range $4,880 USD / £3,270 GBP / €4,110 EUR APC for open access articles if accepted and published.

Submission Instructions

Hematological Oncology accepts the following article types. Click on an article type to view submission instructions.

Original Article

Cover Letter A covering letter signed by the corresponding author is required. The covering letter must state that all authors confirm the work has not been published and is not being considered for publication elsewhere.
Abstract An abstract is required. The abstract must be unstructured and less than 300 words. The abstract must be unstructured.
Manuscript The article must not exceed 3000 words excluding references. The main body must be formatted as introduction, materials and methods, results, discussion, and conclusion. The manuscript must include 3-6 keywords and a data availability statement.
References Original Articles may include a maximum of 80 references. References must follow AMA style.
Figures & Tables Figures must not be embedded in the Word document and may be submitted as separate files. Figures and tables must have legends.
Reformat to Hematological Oncology using Livewrite Premium

Review

Cover Letter A covering letter signed by the corresponding author is required. The covering letter must state on behalf of all authors that the work has not been published and is not being considered for publication elsewhere.
Abstract An abstract is required. The abstract must be unstructured and less than 300 words. The abstract must be unstructured.
Manuscript The main body must be formatted as introduction, materials and methods, results, discussion, and conclusion. The manuscript must include 3-6 keywords and a data availability statement.
References References must follow AMA style. References may be submitted in any consistent style or format at initial submission, but the manuscript references must follow AMA style.
Figures & Tables Figures must not be embedded in the Word document and should be uploaded as separate files. Figures and tables must include legends, and tables must be supplied as editable files rather than pasted as images.
Reformat to Hematological Oncology using Livewrite Premium

Letter To The Editor

Cover Letter A covering letter signed by the corresponding author must be included. The covering letter must state that all authors confirm the work has not been published and is not under consideration elsewhere.
Abstract Abstract must not exceed 300 words. Abstract must be unstructured.
Manuscript Article must not exceed 3000 words excluding references. Main body must be formatted as introduction, materials and methods, results, discussion, and conclusion. Manuscript must include a data availability statement and 3-6 keywords.
References Reference list may include a maximum of 10 references. References must follow AMA style.
Figures & Tables Figures must not be embedded in the Word document and may be uploaded as separate files. Figures and tables must include legends.
Reformat to Hematological Oncology using Livewrite Premium

Case Report

Cover Letter A covering letter signed by the corresponding author must be included.
Abstract An abstract is required. Abstract must be unstructured and less than 100 words. Abstract must be unstructured.
Manuscript Case Reports must not exceed 1,500 words. Manuscript must include the sections abstract, introduction, methods, results, and conclusions. Manuscript must include a data availability statement and 3-6 keywords.
References Case Reports may include a maximum of 10 references. References must follow AMA style.
Figures & Tables Figures must not be embedded in the Word document. Figures and tables must have legends.
Reformat to Hematological Oncology using Livewrite Premium

Recent Publications

Mutational Landscape and Clinical Outcomes in AML With Sole Trisomy 8

Ehsan Bahrami Hezaveh, Mark Anthony Turingan, Qianghua Zhou, Cuihong Wei, Anne Tierens, Hassan Sibai, Hong Chang

10.1002/hon.70207
View Publication

Integrative Transcriptomic and Functional Analysis of PKMYT1 Reveals a Potential Therapeutic Target in Chronic Lymphocytic Leukemia

Elizabete Cristina Iseke Bispo, Cláudia de Souza Lima Pontes, Jennifer Martins do Nascimento, Fábio Wilson de Lima Alves, Juliana Lott de Carvalho, Antônio Roberto Lucena‐Araujo, Felipe Saldanha‐Araujo

10.1002/hon.70208
View Publication

Issue Information

-

10.1002/hon.70196
View Publication

Belumosudil in the Management of Heavily Pretreated Prolonged Chronic GVHD: A Retrospective Multicenter Real‐World Study

Ben Varon, Ron Ram, Avichai Shimoni, Batia Avni, Sigal Grisariu, Vered Stavi, Yael Bar‐On, Moshe Yeshurun, Ronit Elhasid, Aharon Gefen, Asaf Yanir, Odelia Amit, Dana Yehudai‐Ofir, Israel Henig, Tsila Zuckerman

10.1002/hon.70202
View Publication

Identification of miR‐107 and miR‐451‐a as Prognostic Biomarkers in Acute Myeloid Leukemia

Yasmin A. H. S. Younis, Heba Yahia Alsayed Ahmed, Sara A. El Derbaly, Eman Helmy Hebesh, Manal Monir Mansour

10.1002/hon.70206
View Publication

Frequently asked questions

How long does it take to publish?

Median submission to first decision is 13 days, median submission to acceptance is 96 days, and median acceptance to publication is 12 days.

Reformat to Hematological Oncology using Livewrite Premium

Is a cover letter required?

A covering letter is required, signed by the corresponding author, stating on behalf of all authors that the work has not been published and is not being considered for publication elsewhere.

Reformat to Hematological Oncology using Livewrite Premium

What are the publication costs?

$4,880 USD / £3,270 GBP / €4,110 EUR APC applies if the open access option is selected and the article is accepted and published.

Reformat to Hematological Oncology using Livewrite Premium

Research Topics

Lymphoma Diagnosis and Treatment Chronic Lymphocytic Leukemia Research CAR-T cell therapy research CNS Lymphoma Diagnosis and Treatment Viral-associated cancers and disorders Acute Myeloid Leukemia Research Acute Lymphoblastic Leukemia research Lung Cancer Treatments and Mutations Chronic Myeloid Leukemia Treatments Multiple Myeloma Research and Treatments T-cell and Retrovirus Studies Monoclonal and Polyclonal Antibodies Research Immune Cell Function and Interaction Cutaneous lymphoproliferative disorders research Cancer Genomics and Diagnostics Immunodeficiency and Autoimmune Disorders Myeloproliferative Neoplasms: Diagnosis and Treatment Hematopoietic Stem Cell Transplantation Cancer Immunotherapy and Biomarkers Protein Degradation and Inhibitors Cancer Treatment and Pharmacology Multiple and Secondary Primary Cancers Diverse Scientific and Economic Studies Human auditory perception and evaluation Educational Robotics and Engineering

Related Journals

IJ
International Journal Of Dermatology WILEY
PP
Pain Practice WILEY
Ep
Epilepsia WILEY
JO
Journal Of Diabetes WILEY
MO
Molecular Oncology Elsevier BV
CB
Cancer Biology & Therapy Taylor & Francis